Project Scope |
This Project team will create a White Paper with recommendations for Treatment Emergent Definitions, with a focus on Phase 2-4 clinical trials. This White Paper will build upon a White Paper that outlines results from a survey on current practices, indicating variation that can likely be reduced. Recommendations will be based on the desired end-in-mind, and may or may not be consistent with current practices. |
Project Leads | Emails |
---|---|
Mary Nilsson (Eli Lilly) | |
William Palo (Abbvie) | |
Nicola Newton (PHUSE, Project Assistant) |
| ||||||
---|---|---|---|---|---|---|
Working on a White Paper |
Objectives & Deliverables | Timelines |
---|---|
Project team review final White Paper | Q2 2023 |
PHUSE Steering Committee & Public Review | Q3 2023 |
Publish White Paper | Q4 |
Status | ||||
---|---|---|---|---|
|
2023 |
Working on a White Paper
Kirthi Rangaraju